Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease that is often viewed as untreatable. Although no specific treatment for this disease is available, there are important treatable diseases to be considered in the differential and treatable conditions that co-exist or complicate the course of the illness. In this article, we review our current management of patients with ALS.
Gehrig E., Durso J.My Luke and I. New York: Thomas Y. Crowell Co., 1976.
2.
Younger DS, Rowland LP, Latov N.Lymphoma, motor neuron disease, and amyotrophic lareral sclerosis. Ann Neurol1991;29:78-86.
3.
Bradley WGRecent views on amyotrophic lateral sclerosis with emphasis on electrophysiological studies. Muscle & Nerve1987; 10:490-502.
4.
Behnia M., Kelly JJRole of electromyography in amyotrophic lateral sclerosis. Muscle & Nerve1991;14:1236-41.
5.
Bradley WG, Good P., Rasool CG, Adelman LSMorphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis. Ann Neurol1983;14:267-77.
Mitsumoto H. , Hanson MR, Chad DAAmyotrophic lateral sclerosis: recent advances in pathogenesis and therapeutic trials. Arch Neurol1988;40:189-202.
8.
Wiliams DBFamilial amyotrophic lateral sclerosis: the relationship between age-dependent gene expression and patterns of familial aggregation. In: Smith RA (ed.). Handbook of amyotrophic lateral sclerosis. New York: Marcel Dekker , 1992:39-63.
9.
Rosen DR, Siddique T., Patterson D., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature1993;362:59-62.
10.
Armon C., Kurland LT, Smith, GE, Steele JCSporadic and Western Pacific amyotrophic lateral sclerosis: epidemiological considerations. In: Smith RA (ed.). Handbook of amyotrophic lateral sclerosis. New York: Marcel Dekker, 1992:93-131.
11.
Chou SMPathology: light microscopy of amyotrophic lateral sclerosis. In: Smith RA (ed.). Handbook of amyotrophic lateral sclerosis. New York: Marcel Dekker , 1992:133-75.
12.
Lange DJ, Trojaborg WT, Latov N., Hays APMultifocal motor neuropathy with conduction block: a distinct clinical entity?Neurology1992;42:497-505.
13.
Parry JG, Clarke S.Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle & Nerve1988; 11:103-107.
14.
Chaudry V., Corse AM, Cornblath DR, et al. Multifocal motor neuropathy: response to human immune globulin . Ann Neurol1993;33:237-42.
15.
Kaji R., Shibasaki H., Kimura J.Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobin therapy. Neurology1992;42:506-509.
16.
Smith RG, Hamilton HS, Hofmann F., et al. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N Eng J Med1992;327(24):1721-28.
17.
Blacknau METhe psychology of the physically ill patient. A clinician's guide. New York: Plenum Press, 1989.
18.
Caroscio JTAmyotrophic lateral sclerosis: a guide to patient care. New York: Thieme Medical Publishers, 1986.
19.
Hudson AJOutpatient management of amyotrophic lateral sclerosis. SemNeurol1987;7:344-51.
20.
Black LF, Hyatt REMaximal static respiratory pressures in generalized neuromuscular disease . Am Rev Res Dis1971;103:641-50.
21.
Kelly BJ, Luce JMThe diagnosis and management of neuromuscular diseases causing respiratory failure. Chest1991;99:1485-94.
Bradley WGRespirator support in amyotrophic lateral sclerosis. Ann Neurol1982;12:466 (letter).
24.
Moss AH, Casey P.Stocking CB, Roos BR, Siegler M. Home ventilation for amyotrophic lateral sclerosis patients: outcomes, costs, and patient, family, and physician attitudes . Neurology1993; 43:438-43.
25.
Kerby GR, Mayer LS, Pingleton SKNocturnal positive pressure ventilation via nasal mask. Am Rev Res Dis1937;135:738-40.
26.
Ellis ER, Bye Ptp, Bruderer JW, Sullivcan CETreatment of respiratory failure during sleep in patients with neuromuscular disease. Am Rev Res Dis1987;135:148-52.
27.
Bach JR, Alba A., Mosher R., Delaubier A.Intermittent positive pressure ventilation via nasal access in the management of respiratory insufficiency. Chest1987;92:168-70.
